Skip to main content
. 2022 Jan 18;14(3):427. doi: 10.3390/nu14030427

Figure 4.

Figure 4

Change in Body weight (A) and BMI (B) at month 3 and 6 for all participants; * indicates significant difference between groups (p < 0.05) in ITT analysis (active n = 65, placebo n = 71); † indicates significant difference between groups for sub-group participants (BMI > 25–30) in ITT analysis (active n = 48, placebo n = 54); # indicates significant difference between groups for sub-group participants (BMI > 25–30) in pp analysis (active n = 30, placebo n = 38).